Résultats de la recherche - 2 results
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study
chronic disease (OR a 0.22 (95% CI 0.08–0.62)), having received an mRNA-type vaccine (OR a 5.38 (95% CI 1.72–16.80)), and having received an influenza vaccine in 2020–2021 (OR a 3.79 (95% CI 1.30–11.07)). ...
Population vulnerability to COVID-19 in Europe: a burden of disease analysis
health Vulnerability YLD Abstract: Background Evidence has emerged showing that elderly people and those with pre-existing chronic health conditions may be at higher risk of developing severe health ...